502 related articles for article (PubMed ID: 24283858)
21. Comparison of the diagnostic performances of core needle biopsy in myxoid versus non-myxoid tumors.
Rohela H; Lee C; Yoo HJ; Kim HS; Kim Y; Cho HS; Han I
Eur J Surg Oncol; 2019 Jul; 45(7):1293-1298. PubMed ID: 31085026
[TBL] [Abstract][Full Text] [Related]
22. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable?
Hayes-Jordan AA; Spunt SL; Poquette CA; Cain AM; Rao BN; Pappo AS; Shochat SJ
J Pediatr Surg; 2000 Jun; 35(6):948-53; discussion 953-4. PubMed ID: 10873042
[TBL] [Abstract][Full Text] [Related]
23. Bone versus soft-tissue sarcomas in the elderly.
Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
[TBL] [Abstract][Full Text] [Related]
24. Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler M; Gosheger G; Jobke B; Reichardt P; Tunn PU
Br J Cancer; 2015 Feb; 112(3):455-60. PubMed ID: 25535732
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
[TBL] [Abstract][Full Text] [Related]
26. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
[TBL] [Abstract][Full Text] [Related]
27. Anatomic tumor location influences the success of contemporary limb-sparing surgery and radiation among adults with soft tissue sarcomas of the extremities.
Korah MP; Deyrup AT; Monson DK; Oskouei SV; Weiss SW; Landry J; Godette KD
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):933-9. PubMed ID: 21300454
[TBL] [Abstract][Full Text] [Related]
28. Chest wall sarcomas are accurately diagnosed by image-guided core needle biopsy.
Kachroo P; Pak PS; Sandha HS; Nelson SD; Seeger LL; Cameron RB; Eilber FC; Lee JM
J Thorac Oncol; 2012 Jan; 7(1):151-6. PubMed ID: 21900839
[TBL] [Abstract][Full Text] [Related]
29. High diagnostic accuracy of core needle biopsy of soft tissue tumors: An institutional experience.
Colletti SM; Tranesh GA; Whetsell CR; Chambers LN; Nassar A
Diagn Cytopathol; 2016 Apr; 44(4):291-8. PubMed ID: 26799242
[TBL] [Abstract][Full Text] [Related]
30. The Adequacy of Core Biopsy in the Assessment of Smooth Muscle Neoplasms of Soft Tissues: Implications for Treatment and Prognosis.
Schneider N; Strauss DC; Smith MJ; Miah AB; Zaidi S; Benson C; van Houdt WJ; Jones RL; Hayes AJ; Fisher C; Thway K
Am J Surg Pathol; 2017 Jul; 41(7):923-931. PubMed ID: 28505003
[TBL] [Abstract][Full Text] [Related]
31. Soft tissue sarcomas may present with deep vein thrombosis.
Benns M; Dalsing M; Sawchuck A; Wurtz LD
J Vasc Surg; 2006 Apr; 43(4):788-93. PubMed ID: 16616238
[TBL] [Abstract][Full Text] [Related]
32. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
Hasegawa T
Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
[TBL] [Abstract][Full Text] [Related]
33. Core-needle biopsy performed by the cytopathologist: a technique to complement fine-needle aspiration of soft tissue and bone lesions.
Domanski HA; Akerman M; Carlén B; Engellau J; Gustafson P; Jonsson K; Mertens F; Rydholm A
Cancer; 2005 Aug; 105(4):229-39. PubMed ID: 15918176
[TBL] [Abstract][Full Text] [Related]
34. [Results of radiotherapy in recurrences of soft tissue sarcomas].
Schwarz R; Krüll A; Baumann M; Zornig C; Wiegel T; Weh HJ
Strahlenther Onkol; 1996 Feb; 172(2):64-73. PubMed ID: 8669047
[TBL] [Abstract][Full Text] [Related]
35. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
36. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
Yang Z; Tang LH; Klimstra DS
Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
[TBL] [Abstract][Full Text] [Related]
37. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
[TBL] [Abstract][Full Text] [Related]
38. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
39. Are Biopsy Tracts a Concern for Seeding and Local Recurrence in Sarcomas?
Barrientos-Ruiz I; Ortiz-Cruz EJ; Serrano-Montilla J; Bernabeu-Taboada D; Pozo-Kreilinger JJ
Clin Orthop Relat Res; 2017 Feb; 475(2):511-518. PubMed ID: 27655183
[TBL] [Abstract][Full Text] [Related]
40. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
